top of page
image-000.jpg
KakaoTalk_20220111_150124907.png

Aiming To Be a Future Technology Innovation Biohealth Unicorn Company

CarBio Therapeutics

INVESTOR RELATIONS 2024 (IR deck 파일)

​CarBio Therapeutics develops Anti-Cancer CAR-T immune cell therapy for patients suffering from refractory diseases

​Company News

  • Completion of Angel investment                                                                        [2021. 10. 26]

  • Registered as Corporate Affiliated Research Institute                                      [2022. 01. 11]

  • The Family Company  Convention with Cheongju University                       [2022. 02. 07]

951_main.jpg

CarBio Therapeutics

Company: CarBio Therapeutics  |  CEO: 이헌주  | 
Location: 194-25, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do, South Korea
​Business Registration Number: 445-86-02068
Copyrighted ⓒ 2024 CarBio Therapeutics All right reserved.

carbio-light-kor-logo.png
bottom of page